LabCorp 2015 Annual Report Download - page 18

Download and view the complete annual report

Please find page 18 of the 2015 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 151

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151

Index
  LCD has an extensive internal proficiency testing program in which each laboratory receives samples to test. This
internal proficiency program serves to test LCD's analytical and post-analytical phases of laboratory testing service including order entry, requisitioning
systems, accuracy, precision of its testing protocols, and technologist/technician performance. This program supplements the external proficiency programs
required by the laboratory accrediting agencies.
 The Company participates in numerous externally-administered quality surveillance programs, including the College of American
Pathology (CAP) program. CAP is an independent non-governmental organization of board-certified pathologists that offers an accreditation program to
which laboratories voluntarily subscribe. CAP has been granted deemed status authority by CMS to inspect clinical laboratories to determine adherence to
the Clinical Laboratory Improvement Amendments of 1988 (CLIA) standards. The CAP program involves both on-site inspections of the laboratory and
participation in CAP's proficiency testing program for all categories in which the laboratory is accredited. A laboratory's receipt of accreditation by CAP
satisfies the CMS requirement for certification. All of the Company's major diagnostic laboratories and CDD's Phase I clinical research units in Evansville,
Ind. and Dallas, Texas are accredited by CAP.
The Company's forensic crime laboratory located in Lorton, Va. is accredited to ISO/IEC 17025:2005 by the American Society of Crime Laboratory
Directors, Laboratory Accreditation Board (ASCLD/LAB) in the discipline of biology and categories of nuclear DNA, mitochondrial DNA, body fluid
identification and individual characteristic database testing. Under the accreditation program managed by the ASCLD/LAB, a crime laboratory undergoes a
comprehensive and in-depth inspection to demonstrate that its management, operations, employees, procedures and instruments, physical plant, and security
and personnel safety procedures meet stringent quality standards.
The Company's full service forensic facilities in the U.K. are accredited to ISO/IEC 17025:2005 by the U.K. Accreditation Service in many areas of
forensic analysis. These facilities provide crime scene investigative services, collecting samples for DNA analysis, mitochondrial DNA testing, microscopic
analysis of tool marks and paint and other forms of forensic testing.
The Company has multiple labs that have received ISO 15189 accreditation. ISO 15189 is an international standard that recognizes the quality and
technical competence of medical laboratories. The Company has fifteen (15) accredited laboratories in the U.S. In addition, the Company has six (6)
laboratories accredited to this standard outside of the U.S., and the laboratory operated for CDD pursuant to an alliance with BML, Inc. also has this
accreditation. The list below reflects the Company's labs that have achieved this accreditation and the year in which they achieved it.
LCD
• Colorado Coagulation, Denver, Colorado - January, 2016
• Dynacare-Gamma facility, Laval, Québec - March, 2015
• LabCorp’s Regional Testing Facility, Dublin, Ohio - March, 2015
• Endocrine Sciences, Calabasas, California - January, 2015
• LabCorp's Regional Testing Facility, Dallas, Texas - April, 2014
• LabCorp's Regional Testing Facility, Denver, Colorado - March, 2014
• Integrated Genetics, Santa Fe, New Mexico - October, 2013
• Integrated Genetics, Westborough, Massachusetts - September, 2013
• Dynacare-Gamma facility, Montreal, Québec - June 2013
• LabCorp's Regional Testing Facility, Phoenix, Arizona - April, 2013
• LabCorp's Regional Testing Facility, Birmingham, Alabama - February, 2013
• Integrated Oncology, Brentwood, Tenenssee - February, 2012
• Viromed, Burlington, North Carolina - January, 2012
• Center for Molecular Biology and Pathology (CMBP), Research Triangle Park, North Carolina - February, 2011
• LabCorp's Regional Testing Facility, Tampa, Florida - January, 2010
• Integrated Oncology, Phoenix, Arizona - September, 2009
CDD
• Covance Central Laboratory Services Inc., Indianapolis, Indiana - August, 2015
• BML Covance Central Laboratory, Tokyo, Japan - March, 2015 (Operated for CDD pursuant to an alliance with BML, Inc.)
• Covance Pharmaceutical Research and Development (Shanghai) Co. Ltd, Shanghai, China - March, 2015
• Covance (Asia) Pte. Ltd., Singapore - June, 2014
• Covance Central Laboratory Services SA, Geneva, Switzerland - October, 2013
18